{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:36:16Z","timestamp":1784334976155,"version":"3.55.0"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2014,8,22]],"date-time":"2014-08-22T00:00:00Z","timestamp":1408665600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0105555","type":"journal-article","created":{"date-parts":[[2014,8,22]],"date-time":"2014-08-22T15:26:06Z","timestamp":1408721166000},"page":"e105555","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Intermittent Hypoxia Effect on Osteoclastogenesis Stimulated by Neuroblastoma Cells"],"prefix":"10.1371","volume":"9","author":[{"given":"Vasantha Kumar","family":"Bhaskara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indra","family":"Mohanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena","family":"Gujrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeeva","family":"Mohanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,8,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01.mop.0000150631.60571.89","article-title":"The biologic basis for neuroblastoma heterogeneity and risk stratification","volume":"17","author":"JM Maris","year":"2005","journal-title":"Curr Opin Pediatr"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","article-title":"Neuroblastoma","volume":"369","author":"JM Maris","year":"2007","journal-title":"Lancet"},{"key":"ref3","first-page":"659","article-title":"A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage","volume":"75","author":"JC Hoehner","year":"1996","journal-title":"Lab Invest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/onc.2009.518","article-title":"Molecular pathogenesis of peripheral neuroblastic tumors","volume":"29","author":"I Janoueix-Lerosey","year":"2010","journal-title":"Oncogene"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00148581-200406020-00004","article-title":"Neuroblastoma: evolving therapies for a disease with many faces","volume":"6","author":"RE Goldsby","year":"2004","journal-title":"Paediatr Drugs"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJM199910143411601","article-title":"Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group","volume":"341","author":"KK Matthay","year":"1999","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0304-3835(03)00108-3","article-title":"Retinoid therapy of high-risk neuroblastoma","volume":"197","author":"CP Reynolds","year":"2003","journal-title":"Cancer Lett"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","article-title":"Hypoxia in cancer: significance and impact on clinical outcome","volume":"26","author":"P Vaupel","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10555-007-9056-0","article-title":"Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment","volume":"26","author":"BJ Moeller","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2005.06.038","article-title":"Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study","volume":"77","author":"M Nordsmark","year":"2005","journal-title":"Radiother Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/cncr.21983","article-title":"The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer","volume":"107","author":"SC Winter","year":"2006","journal-title":"Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1200\/JCO.2005.02.7474","article-title":"Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial","volume":"24","author":"MI Koukourakis","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","article-title":"Exploiting tumour hypoxia in cancer treatment","volume":"4","author":"JM Brown","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/j.1349-7006.2003.tb01395.x","article-title":"Tumor hypoxia: a target for selective cancer therapy","volume":"94","author":"S Kizaka-Kondoh","year":"2003","journal-title":"Cancer Sci"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia\u2014a key regulatory factor in tumour growth","volume":"2","author":"AL Harris","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"ref16","first-page":"941","article-title":"Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma","volume":"56","author":"DM Brizel","year":"1996","journal-title":"Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0360-3016(01)01662-5","article-title":"Tumor size and oxygenation are independent predictors of nodal diseases in patients with cervix cancer","volume":"51","author":"G Pitson","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/bjc.1998.586","article-title":"Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix","volume":"78","author":"K Sundfor","year":"1998","journal-title":"Br J Cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1158\/0008-5472.CAN-06-4744","article-title":"Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting","volume":"67","author":"MW Dewhirst","year":"2007","journal-title":"Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/02841860152708206","article-title":"Clinical relevance of intermittent tumour blood flow","volume":"40","author":"RE Durand","year":"2001","journal-title":"Acta Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"11736","DOI":"10.1158\/0008-5472.CAN-06-2056","article-title":"Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies","volume":"66","author":"P Martinive","year":"2006","journal-title":"Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1111\/j.1742-4658.2008.06454.x","article-title":"Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours","volume":"275","author":"S Toffoli","year":"2008","journal-title":"FEBS J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10059-010-0067-2","article-title":"HIF-1 and HIF-2 transcription factors\u2014similar but not identical","volume":"29","author":"A Loboda","year":"2010","journal-title":"Mol Cells"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"GL Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrc3064","article-title":"Targeting hypoxia in cancer therapy","volume":"11","author":"WR Wilson","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1742-4658.2008.06798.x","article-title":"Impact of cyclic hypoxia on HIF-1alpha regulation in endothelial cells\u2014new insights for anti-tumor treatments","volume":"276","author":"P Martinive","year":"2009","journal-title":"FEBS J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.canlet.2005.01.059","article-title":"Mechanisms of bone invasion and metastasis in human neuroblastoma","volume":"228","author":"Y Sohara","year":"2005","journal-title":"Cancer Lett"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pcl.2007.10.014","article-title":"Neuroblastoma: biology, prognosis, and treatment","volume":"55","author":"JR Park","year":"2008","journal-title":"Pediatr Clin North Am"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1634\/theoncologist.8-3-278","article-title":"Advances in the diagnosis and treatment of neuroblastoma","volume":"8","author":"JL Weinstein","year":"2003","journal-title":"Oncologist"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ijc.23951","article-title":"The hemopexin domain of MMP-9 inhibits angiogenesis and retards the growth of intracranial glioblastoma xenograft in nude mice","volume":"124","author":"R Ezhilarasan","year":"2009","journal-title":"Int J Cancer"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/15216540500137669","article-title":"RANKing intracellular signaling in osteoclasts","volume":"57","author":"X Feng","year":"2005","journal-title":"IUBMB Life"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0006-291X(03)00695-8","article-title":"Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts","volume":"305","author":"ZH Lee","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1476-4598-9-185","article-title":"A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients","volume":"9","author":"P Fardin","year":"2010","journal-title":"Mol Cancer"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2559.2012.04227.x","article-title":"HIF-1alpha up-regulation is associated with adverse clinicopathological and biological factors in neuroblastomas","volume":"61","author":"JV Dungwa","year":"2012","journal-title":"Histopathology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e30905","DOI":"10.1371\/journal.pone.0030905","article-title":"Intermittent Hypoxia Regulates Stem-like Characteristics and Differentiation of Neuroblastoma Cells","volume":"7","author":"VK Bhaskara","year":"2012","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1158\/0008-5472.CAN-03-3196","article-title":"Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma","volume":"64","author":"RA Cairns","year":"2004","journal-title":"Cancer Res"},{"key":"ref37","first-page":"8903","article-title":"Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors","volume":"61","author":"RA Cairns","year":"2001","journal-title":"Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1158\/1535-7163.MCT-07-2059","article-title":"Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha","volume":"7","author":"M Puppo","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1593\/neo.06670","article-title":"Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma","volume":"9","author":"L Zhang","year":"2007","journal-title":"Neoplasia"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.jpedsurg.2004.06.019","article-title":"CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases","volume":"39","author":"HV Russell","year":"2004","journal-title":"J Pediatr Surg"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ijc.20308","article-title":"In vitro blockade of receptor activator of nuclear factor-kappaB ligand prevents osteoclastogenesis induced by neuroblastoma cells","volume":"111","author":"D Granchi","year":"2004","journal-title":"Int J Cancer"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10555-006-9028-9","article-title":"Mechanisms of invasion and metastasis in human neuroblastoma","volume":"25","author":"T Ara","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","article-title":"RANKL-RANK signaling in osteoclastogenesis and bone disease","volume":"12","author":"T Wada","year":"2006","journal-title":"Trends Mol Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature09387","article-title":"Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer","volume":"468","author":"D Schramek","year":"2010","journal-title":"Nature"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10059-011-1055-x","article-title":"Hypoxia inducible factor-1alpha directly induces the expression of receptor activator of nuclear factor-kappaB ligand in periodontal ligament fibroblasts","volume":"31","author":"HJ Park","year":"2011","journal-title":"Mol Cells"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.bbrc.2010.02.086","article-title":"Activation of the hypoxia-inducible factor-1 in overloaded temporomandibular joint, and induction of osteoclastogenesis","volume":"393","author":"M Shirakura","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1152\/jappl.2000.88.4.1474","article-title":"HIF-1: mediator of physiological and pathophysiological responses to hypoxia","volume":"88","author":"GL Semenza","year":"2000","journal-title":"J Appl Physiol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1101\/gad.11.24.3482","article-title":"Requirement for NF-kappaB in osteoclast and B-cell development","volume":"11","author":"G Franzoso","year":"1997","journal-title":"Genes Dev"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1074\/jbc.M209299200","article-title":"PTEN regulates RANKL- and osteopontin-stimulated signal transduction during osteoclast differentiation and cell motility","volume":"278","author":"T Sugatani","year":"2003","journal-title":"J Biol Chem"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1158\/0008-5472.CAN-05-1448","article-title":"Insulin-like growth factor-I receptor expression regulates neuroblastoma metastasis to bone","volume":"66","author":"CM van Golen","year":"2006","journal-title":"Cancer Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1158\/0008-5472.CAN-06-2355","article-title":"Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer","volume":"67","author":"T Hiraga","year":"2007","journal-title":"Cancer Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1158\/0008-5472.CAN-09-3739","article-title":"In vivo dynamics and distinct functions of hypoxia in primary tumor growth and organotropic metastasis of breast cancer","volume":"70","author":"X Lu","year":"2010","journal-title":"Cancer Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S8756-3282(96)00351-1","article-title":"Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry","volume":"20","author":"A Littlewood-Evans","year":"1997","journal-title":"Bone"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1096\/fj.06-6304fje","article-title":"The calcium sensing receptor is directly involved in both osteoclast differentiation and apoptosis","volume":"20","author":"R Mentaverri","year":"2006","journal-title":"FASEB J"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1084\/jem.190.2.293","article-title":"Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption","volume":"190","author":"S Niida","year":"1999","journal-title":"J Exp Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1083\/jcb.151.4.879","article-title":"Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones","volume":"151","author":"MT Engsig","year":"2000","journal-title":"J Cell Biol"},{"key":"ref57","first-page":"309","article-title":"A possible role of VEGF in osteolytic bone metastasis of hepatocellular carcinoma","volume":"21","author":"H Iguchi","year":"2002","journal-title":"J Exp Clin Cancer Res"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0014-5793(00)01520-9","article-title":"Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts","volume":"473","author":"M Nakagawa","year":"2000","journal-title":"FEBS Lett"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/sj.bjc.6602417","article-title":"Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone","volume":"92","author":"SE Aldridge","year":"2005","journal-title":"Br J Cancer"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/path.2319","article-title":"Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF","volume":"215","author":"HJ Knowles","year":"2008","journal-title":"J Pathol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"WJ Boyle","year":"2003","journal-title":"Nature"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"GR Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"GD Roodman","year":"2004","journal-title":"N Engl J Med"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1007\/s00381-012-1909-3","article-title":"Establishment and characterization of xenograft models of human neuroblastoma bone metastasis","volume":"28","author":"H Zhao","year":"2012","journal-title":"Childs Nerv Syst"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0198763","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T00:00:00Z","timestamp":1528156800000},"record-id":"18327"},{"DOI":"10.1371\/journal.pone.0170156","type":"correction","label":"Correction","source":"retraction-watch","updated":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T00:00:00Z","timestamp":1484265600000},"record-id":"18328"},{"DOI":"10.1371\/journal.pone.0170156","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T00:00:00Z","timestamp":1484265600000}},{"DOI":"10.1371\/journal.pone.0198763","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T00:00:00Z","timestamp":1528156800000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0105555","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T02:14:44Z","timestamp":1565748884000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0105555"}},"subtitle":[],"editor":[{"given":"Dominique","family":"Heymann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,8,22]]},"references-count":64,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0105555","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0170156","asserted-by":"object"}],"retraction":[{"id-type":"doi","id":"10.1371\/journal.pone.0198763","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,22]]}}}